Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Types of COPD: Symptoms, Treatments, and More |
|
| 2 | Korean Quality Assessment Program Found to Be Effective at Improving COPD Care |
|
| 3 | COVID-19 Has Devastating Effects for Patients Suffering From COPD |
|
| 4 | Stage 1 COPD: Symptoms, treatment, and outlook |
|
| 5 | UK Study Finds Off-Label Prescribing of COPD Therapies Is Low |
|
| 6 | Beta-Blockers May Reduce COPD Exacerbations Without Negative Effect on Mortality |
|
| 7 | Improvement in lung function and patient-reported outcomes i | COPD |
|
| 8 | Review on Blended Self-management Shows Mixed Results on Relieving COPD Burden |
|
| 9 | EP. 6: Dr Nicola Hanania on the Future of COPD Research |
|
| 10 | Treatable Traits and Eosinophil Counts: Drug Therapy in COPD |
|
| 11 | Chest CT Accurate in Estimating All-Cause COPD Mortality Risk |
|
| 12 | Long-Term Pulmonary Rehabilitation Maintenance Program Can Be Beneficial in COPD |
|
| 13 | Researchers Identify Patients With COPD at Risk for Hypercapnia Development |
|
| 14 | COPD Stakeholder Summit—Individualizing Treatment and Improving Outcomes, Part 2 |
|
| 15 | Paradoxical Effect From Bronchodilators Linked to Worse Quality of Life in COPD |
|
| 16 | Study Finds Depression, Anxiety to Be More Common in COPD Than Other Chronic Comorbidities |
|
| 17 | Chest CT illuminates mortality risk in people with COPD |
|
| 18 | What is shortness of breath? Causes and when to contact a doctor |
|
| 19 | CT-derived body composition assessment may signal mortality risk in COPD |
|
| 20 | Nonmedical Switching Led to Gaps in COPD Care, Study Says |
|
| 21 | Tiny Lung Valve Eases Breathing in Emphysema/COPD Patients |
|
| 22 | Construction Workers Are at an Increased Risk for COPD |
|
| 23 | Noninvasive ventilation acutely improves endothelial function in exacerbated COPD patients |
|
| 24 | Long-Term Exposure to Particulate Matter Increases CV Mortality Risk in COPD |
|
| 25 | Study Finds 3-Fold Higher Care Costs for Patients With COPD Than Healthy Patients |
|
| 26 | Possible Value in Using Clinically Important Deterioration as COPD Prognosis Indicator |
|
| 27 | Study Links Risk of Excessive Blood CO2 to Certain COPD Complications |
|
| 28 | Respiratory Symptoms Questionnaire Validated Tool for Asthma and/or COPD |
|
| 29 | Circ-OSBPL2 contributes to smoke-related COPD | COPD |
|
| 30 | [Full text] CHARACTERISTICS OF COPD PHENOTYPES IN SERBIA | COPD |
|
| 31 | Virtual Pulmonary Rehabilitation Programs for COPD Must Continue to Address Patient Access |
|
| 32 | TLD helping COPD patients to breathe easier |
|
| 33 | UArizona researching personalized treatments for COPD |
|
| 34 | COPD and COVID-19: Risks, Complications, Considerations |
|
| 35 | Easyhaler Use in COPD or Asthma Generates Sufficient Inspiratory Flows |
|
| 36 | Predicting Hospitalization Due to COPD Exacerbations in Swedish Primar | COPD |
|
| 37 | Chest CT Indicates Mortality Risk in COPD |
|
| 38 | Emphysema underdiagnosed, but low-dose CT provides opportunity to identify, intervene |
|
| 39 | Cough Systems Market Growth Pursuant to Rising COPD Burden Worldwide |
|
| 40 | Fungi are present in your lungs |
|
| 41 | A Pandemic Spotlight on COPD |
|
| 42 | Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease i | COPD |
|
| 43 | COPD Foundation, DevPro Biopharma Partner to Boost New Therapy... |
|
| 44 | COPD rehabilitation in Veterans' homes bolstered by VA Video Connect |
|
| 45 | Eosinophilic COPD Exacerbations Not Predictive of Moderate, Severe Relapses |
|
| 46 | [Full text] Digital Resources to Support COPD Self-Management | JMDH |
|
| 47 | 2 Distinct Patterns of Coexisting Disorders Observed in COPD, Study Says |
|
| 48 | Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial |
|
| 49 | Small airway determinants of airflow limitation in chronic obstructive pulmonary disease |
|
| 50 | Long-term air pollution exposure may elevate risk for CV mortality in patients with COPD |
|
| 51 | COPD Foundation and DevPro Biopharma Join Forces to Develop Treatments for People with COPD and Related Lung Conditions |
|
| 52 | Pulmonary rehabilitation confers long-term benefits in patients with COPD |
|
| 53 | Prediction of Mortality Using Different COPD Risk Assessments – | COPD |
|
| 54 | Study of Lung Health Among Blacks Earns CHEST Foundation Grant |
|
| 55 | FDA Approval Sought for New Generic Version of Advair Diskus |
|
| 56 | Health care affordability, racial disparities persist in individuals with asthma, COPD |
|
| 57 | You've Got Fungi in Your Lungs, and That's OK |
|
| 58 | Outcomes Poorer for PH-COPD Than Idiopathic PAH, Registry Data Show |
|
| 59 | Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study |
|
| 60 | Noninvasive Ventilation During Sleep May Be Beneficial for Patients With COPD |
|
| 61 | Acute Viral Infections May Lead to COPD via Sentinel Immune Cells |
|
| 62 | Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD |
|
| 63 | Chronic Obstructive Pulmonary Disorder (COPD) Market 2021 Analysis and Precise Outlook – 2026; GSK, Pfizer, Merck, Novartis, AstraZeneca, Boehringer Ingelheim – KSU | The Sentinel Newspaper |
|
| 64 | Effects of influenza vaccination on clinical outcomes of chronic obstructive pulmonary disease: A systematic review and meta-analysis |
|
| 65 | Pharmaceutical Intermediates Market to see growth |
|
| 66 | Nashville woman with lung disease issues plea for help with flooding issue at residence |
|
| 67 | Chronic Obstructive Pulmonary Disease (COPD) Treatment Market expected to expand at a CAGR of ~5% during the forecast period of 2019 to 2027 – KSU | The Sentinel Newspaper |
|
| 68 | COPD Drugs Market Key Business Opportunities, Impressive Growth Rate and Development Analysis to 2026 – SoccerNurds |
|
| 69 | Virtual 'Cycle the Seacoast' raises funds for lung disease |
|
| 70 | Global Drugs for Asthma and COPD Market 2021 Development Analysis – GSK, Pfizer, Novartis, Abbott, Boehringer Ingelheim, Merck, Teva, AstraZeneca – KSU | The Sentinel Newspaper |
|
| 71 | Global COPD Devices Market latest Industry Developments and Future Growth Opportunities – KSU | The Sentinel Newspaper |
|
| 72 | Global Asthma & COPD Market Key Trends Analysis and Strategic Analysis Forecast 2021- 2026 |
|
| 73 | There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF) |
|
| 74 | Global COPD & Asthma Devices Market Growth/Extension is expected to amplify market Key Trends, Growth Demand and Leading Players Anlysis by 2020-2027 |
|
| 75 | The Search for new COPD Therapies |
|
| 76 | 5 Early-Life Risk Factors for COPD |
|
| 77 | Interactives Case Studies (March 2021) |
|
| 78 | Consider New Treatment Options for COPD |
|
| 79 | Top 5 Most-Read COPD Stories of 2020 |
|
| 80 | Your Lungs Are Teeming With Fungi, And That's Not Necessarily A Bad Thing |
|
| 81 | COPD Before the Age of 50 Often Associated With Family History, Study Says |
|
| 82 | EP. 1: COPD & COVID-19: An Interview With Dr MeiLan Han |
|
| 83 | Asthma and COPD Drugs Market to Exhibit Continuous Growth till 2027 | Players – Boehringer Ingelheim, Novartis AG, GlaxoSmithKline, Merck and Co. – KSU | The Sentinel Newspaper |
|
| 84 | Types and stages of COPD: Symptoms, causes, and more |
|
| 85 | Doctors' Group Says Antibiotics Can Be Taken for Shorter Periods |
|
| 86 | Does COPD Progress after Quitting Smoking: Your FAQs |
|
| 87 | Are Patients With COPD More Vulnerable to COVID-19? |
|
| 88 | Respiratory Drugs Market Size 2021 | Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report 2021-2028 |
|
| 89 | COPD and Asthma May Not Be Risk Factors for COVID-19, Study Says |
|
| 90 | Study Finds Variation in COPD Characteristics by Risk Factors |
|
| 91 | Rapid AI Penetration to Drive Growth of Global MR Vital Sign Monitors Market |
|
| 92 | Science: The app helps COPD patients take the necessary measures if the disease gets worse |
|
| 93 | Targeting Chronic Obstructive Pulmonary Disease Endotypes |
|
| 94 | COPD and the microbiome |
|
| 95 | COPD and cough: Link, treatment, and more |
|
| 96 | FDA Grants 510(k) Clearance to Pulsehaler for Respiratory Disease Relief |
|
| 97 | COVID-19 With COPD: Fewer Hospitalizations, But Greater Mortality |
|
| 98 | Drowning in fear? Reach for God’s hand in the ‘storm’ |
|
| 99 | Diagnostic accuracy of lung point-of-care ultrasonography for acute heart failure compared with chest x-ray study among dyspneic older patients in the emergency department |
|
| 100 | The Need for New Biological Targets for Therapeutic Intervention in COPD |
|